AI-GF-GNW on Prolonged Grief Reactions
AI-Assisted Grief-Focused Guided Narrative Writing for Subclinical Prolonged Grief Disorder in Bereaved Chinese Adolescents: A Three-Arm Parallel Randomized Controlled Trial.
Prolonged Grief Disorder (PGD) is a severe, disabling condition characterized by intense yearning and difficulty accepting the reality of loss, which significantly impairs the academic and psychosocial functioning of bereaved adolescents. While Grief-Focused Cognitive Behavioral Therapy (GF-CBT) is effective, its high cost and resource-intensive nature limit its accessibility for adolescents in mainland China. Grief-Focused Guided Narrative Writing (GF-GNW) offers a scalable, low-cost alternative that facilitates memory integration.
Furthermore, integrating Artificial Intelligence (AI) to provide personalized, structured feedback has the potential to simulate therapist functions and enhance intervention efficacy. However, the specific efficacy of AI-assisted feedback in this context remains empirically unvalidated.
This parallel randomized controlled trial aims to examine the effectiveness of AI-assisted GF-GNW (AI-GF-GNW) in treating Chinese adolescents (aged 10-19) with subclinical PGD, compared to a no-feedback NF-GF-GNW group and a free writing group. Primary outcomes include PGD symptom severity, while secondary outcomes assess depression, anxiety, and daily functioning. We hypothesize that both active intervention arms will significantly alleviate PGD and related symptoms compared to the free writing group, and that the AI-GF-GNW group will demonstrate a significantly greater reduction in symptoms and functional impairment than the NF-GF-GNW group.
Studieoversigt
Status
Betingelser
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Yinyin Zang, PhD
- Telefonnummer: +86-010-62756953
- E-mail: yinyin.zang@pku.edu.cn
Studiesteder
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, Kina
- Peking University
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
- Voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- Junior and senior high school students currently studying in Chinese Mainland, aged 10-19;
- Between 6 and 60 months prior to the experimental period, experienced the death of a significant family member or close friend or close friend;
- The total symptom score of PG-13-R is between 20-29 points;
- Ability to write and understand written guidelines, to use the mobile phone to interact with AI;
- Consent to participate in the study.
Exclusion Criteria:
- Diagnosed or previously diagnosed with mental illness
- The bereavement time does not meet the time window
- PG-13-R score is not within the range
- At present, there is suicidal ideation or recent severe self harm behavior (Reynolds' Suicidal Ideation Questionnaire, SIQ-JR-4>0), and a crisis intervention hotline is provided when necessary.
- Has received other grief counseling or is currently taking psychiatric medication within the past month
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Tredobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: AI-GF-GNW
|
Participants will independently complete the intervention writing tasks via the H5 platform.
Participants were required to complete a 6-day, 3-session narrative writing task.
Each session requires more than 20 minutes of uninterrupted writing.
Session 1 requires describing the specific details and feelings of the bereavement event; Session 2 requires describing the negative impact of the event and one's own negative feelings; Session 3 requires a description of the positive impact of the event and one's own positive feelings, with a one-day interval between each session, synchronized with the NF-GF-GNW group.
When participants complete and submit their writing, they will immediately receive a response generated by the AI large language model.
Participants are not allowed to engage in any additional interaction with the AI large language model other than submitting writing content and receiving feedback.
|
|
Eksperimentel: NF-GF-GNW
|
All processes are the same as the AI-GF-GNW group, except that when participants complete their writing and submit, the platform will only display a "submission successful" prompt and will not provide any feedback on the writing content.
|
|
Aktiv komparator: FWG
|
Participants in the FWG will not receive structured guidance, and are only required to write freely about their loss experiences.
The writing sessions will follow the same schedule and duration as the other groups.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Prolonged Grief Disorder-13-Revision (PG-13-R)
Tidsramme: Baseline (0 Day), post-treatment assessment (5 Day), follow-up assessment (35 Day)
|
PG-13-R is a standardized diagnostic tool designed to assess the severity of prolonged grief disorder symptoms over the past month.
The instrument consists of 10 questions scored on a 5-point Likert scale, alongside 2 true/false questions and 1 open-ended question assessing functional impairment and duration.Who gets 30 points or higher will be considered as clinical prolonged grief reactions.
|
Baseline (0 Day), post-treatment assessment (5 Day), follow-up assessment (35 Day)
|
|
Patient Health Questionnaire (PHQ-9)
Tidsramme: Baseline (0 Day), post-treatment assessment (5 Day), follow-up assessment (35 Day)
|
PHQ-9 is a brief, validated screening tool used to measure the severity of depression symptoms in adolescents over the past two weeks.
9 questions are scored on a Likert scale of 0-3 with 0 being not at all and 3 being nearly every day.
|
Baseline (0 Day), post-treatment assessment (5 Day), follow-up assessment (35 Day)
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Generalized Anxiety Disorder (GAD-7)
Tidsramme: Baseline (0 Day), post-treatment assessment (5 Day), follow-up assessment (35 Day)
|
GAD-7 is an easy-to-perform initial screening tool for generalized anxiety disorder.
Questions are scored on a Likert scale of 0-3 with 0 being not at all and 3 being nearly every day.
|
Baseline (0 Day), post-treatment assessment (5 Day), follow-up assessment (35 Day)
|
|
WHO Disability Assessment Schedule-short version(WHODAS 2.0)
Tidsramme: Baseline (0 Day), post-treatment assessment (5 Day), follow-up assessment (35 Day)
|
WHODAS 2.0 is a comprehensive instrument developed by the World Health Organization to measure health status and functional disability across six core domains over the past 30 days.
12 questions are scored on a Likert scale of 1-5 with 1 being no difficulty and 5 being extreme difficulty.
|
Baseline (0 Day), post-treatment assessment (5 Day), follow-up assessment (35 Day)
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- AI-assisted Grief-Focused GNW
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .